We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

DYMIND BIOTECHNOLOGY

Dymind designs, manufactures and sells a range of auto hematology analyzers and home ventilator. The company also off... read more Featured Products: More products

Download Mobile App





Dymind Presents Advanced Automatic Hematology Analysis Line

By LabMedica International staff writers
Posted on 06 Feb 2025

Dymind Biotechnology (Shenzhen, China) is presenting its comprehensive range of healthcare solutions at Medlab Middle East 2025, covering the fields of hematology, coagulation, immunoassay, POCT and veterinary. More...

Dymind is presenting the DH-8000 advanced hematology analysis workstation that provides a comprehensive testing solution for whole blood, capillary blood, body fluids, and pre-diluted samples. It is designed to enhance the user's experience in high-volume sample testing, by minimizing manual intervention and maximizing efficiency. Dymind is also showcasing the upgraded DH-800 auto hematology analyzer with AI technology that provides more accurate and efficient diagnosis. Also featured at the event is the MF1280 novel multiplex platform for allergy and autoimmunity testing that delivers rapid results for all tested items within a single test portfolio, significantly increasing diagnostic efficiency.

At the 2025 edition of Medlab Middle East, Dymind is highlighting the CA1200 fully automated coagulation analyzer that combines the optical and mechanical methods for clotting assays, while being able to intelligent switch from two methods when an abnormal sample is detected, to ensure both test accuracy and cost-effectiveness. In addition, Dymind is showcasing the innovative DP-H50 automatic 5-part hematology analyzer that integrates immunoassay and chemistry. With capabilities for joint tests in CBC, immunofluorescence, colloidal gold, and the chemistry module, the DP-H50 offers 5 test modes with single-package reagents to meet diverse demands. Among its veterinary solutions, Dymind is showcasing the automatic AI morphology analyzer, the D-wise, 5-part automatic hematology analyzer with RET, DM61 Vet, and DP-H10 Vet POCT hematology analyzer.


New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Group of human colon cancer cells with invasive behavior (Photo courtesy of Ariel Ruiz i Altaba/UNIGE)

AI Algorithm Predicts Cancer Metastasis and Recurrence Risk

Some tumors spread to distant organs while others remain localized, making it one of the most critical unanswered questions in cancer care. Metastasis is the leading cause of death in most cancers, yet... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.